Dimensional Fund Advisors
HEPA

Dimensional Fund Advisors’s Hepion Pharmaceuticals HEPA Stock Holding History

Dimensional Fund Advisors’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-33
Closed -$93K – 3343
2020
Q2 		$93K Hold
33
– – ﹤0.01% 3279
2020
Q1 		$58K Buy
+33
New +$132K ﹤0.01% 3310

Other funds holding HEPA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Dimensional Fund Advisors's HEPA Position: Q3 2020 in Review

Dimensional Fund Advisors sold out of Hepion Pharmaceuticals (HEPA) in Q3 2020, closing a stake of 33 shares — an estimated $93K sold.

Dimensional Fund Advisors first reported a position in HEPA in Q1 2020 and held it in 2 quarters. The position peaked at $93K in Q2 2020. 12 funds tracked by Wall St. Rank hold HEPA as of Q3 2020.

  • Dimensional Fund Advisors reported no remaining Hepion Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Dimensional Fund Advisors sold 33 Hepion Pharmaceuticals shares in Q3 2020, an estimated $93K.
  • Dimensional Fund Advisors first reported a position in Hepion Pharmaceuticals in Q1 2020 and held it in 2 quarters.
  • Dimensional Fund Advisors's Hepion Pharmaceuticals position peaked at $93K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q3 2020.

Based on Dimensional Fund Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.